. 2016 Mar 4;7(14):18984–18998. doi: 10.18632/oncotarget.7920

Table 4. Association between the rs1054135 genotype and the risk of TNBC relapse (validation cohort).

SNP	genotype	Disease-free (%)	Relapse (%)	HR^a (95% CI)	P value
rs1054135	AA+AG	88(80.0)	42 (95.5)	1.00(Reference)
	GG	22 (20.0)	2(4.5)	0.14(0.03-0.66)	0.0026

Hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between SNPs and recurrence & metastasis risk was adjusted for age, tumour size (≤2cm and >2 cm), lymph-node involvement (no and yes), histological type, menopausal status (no and yes), vascular invasion (no and yes), breast or ovarian cancer history (no and yes), taxane/anthracycline-based chemotherapy (yes or no) and radiotherapy (no and yes).